Blouin Ashley M, Sillivan Stephanie E, Joseph Nadine F, Miller Courtney A
Department of Metabolism and Aging and Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida 33458, USA.
Department of Metabolism and Aging and Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida 33458, USA
Learn Mem. 2016 Sep 15;23(10):576-86. doi: 10.1101/lm.040485.115. Print 2016 Oct.
Prolonged distress and dysregulated memory processes are the core features of post-traumatic stress disorder (PTSD) and represent the debilitating, persistent nature of the illness. However, the neurobiological mechanisms underlying the expression of these symptoms are challenging to study in human patients. Stress-enhanced fear learning (SEFL) paradigms, which encompass both stress and memory components in rodents, are emerging as valuable preclinical models of PTSD. Rodent models designed to study the long-term mechanisms of either stress or fear memory alone have identified a critical role for numerous epigenetic modifications to DNA and histone proteins. However, the epigenetic modifications underlying SEFL remain largely unknown. This review will provide a brief overview of the epigenetic modifications implicated in stress and fear memory independently, followed by a description of existing SEFL models and the few epigenetic mechanisms found to date to underlie SEFL. The results of the animal studies discussed here highlight neuroepigenetics as an essential area for future research in the context of PTSD through SEFL studies, because of its potential to identify novel candidates for neurotherapeutics targeting stress-induced pathogenic memories.
长期的痛苦和记忆过程失调是创伤后应激障碍(PTSD)的核心特征,代表了该疾病使人衰弱的持续性本质。然而,这些症状表现背后的神经生物学机制在人类患者中很难进行研究。应激增强恐惧学习(SEFL)范式,其中包含啮齿动物中的应激和记忆成分,正逐渐成为创伤后应激障碍有价值的临床前模型。旨在单独研究应激或恐惧记忆长期机制的啮齿动物模型已经确定了DNA和组蛋白的大量表观遗传修饰的关键作用。然而,应激增强恐惧学习背后的表观遗传修饰在很大程度上仍然未知。本综述将简要概述与应激和恐惧记忆独立相关的表观遗传修饰,接着描述现有的应激增强恐惧学习模型以及迄今为止发现的少数作为应激增强恐惧学习基础的表观遗传机制。此处讨论的动物研究结果凸显了神经表观遗传学作为创伤后应激障碍未来研究重要领域的地位,通过应激增强恐惧学习研究,因为其有潜力识别针对应激诱导的致病性记忆的神经治疗新候选物。